2576 studies found for:    "Hepatitis"
Show Display Options
Rank Status Study
21 Completed Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
22 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
23 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
24 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir
25 Completed A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-450/r;   Drug: ABT-530;   Drug: Ribavirin (RBV)
26 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
27 Completed Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
Conditions: Hepatitis C Virus;   Chronic Liver Disease;   Viral Hepatitis;   Therapeutic Uses;   Antiviral Agents
Intervention: Drug: peginterferon plus ribavirin
28 Completed
Has Results
A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
29 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™ ADULT;   Biological: Engerix TM
30 Completed Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
Conditions: Chronic Hepatitis C;   Hepatitis, Viral, Human
Intervention: Drug: EMZ702
31 Terminated Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
Conditions: Chronic Hepatitis;   Hepatitis B
Interventions: Drug: Clevudine;   Drug: Adefovir
32 Completed
Has Results
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™
33 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
34 Withdrawn A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Conditions: Hepatitis C;   Hepatitis C Virus
Interventions: Drug: Fluvastatin;   Drug: Peginterferon alfa2a;   Drug: ribavirin
35 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
36 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
37 Recruiting Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C;   Genotype 4 Chronic Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
38 Unknown  Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
Conditions: Hepatitis C;   Hepatitis B
Intervention: Drug: Pegasys; Copegus.
39 Completed
Has Results
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
Conditions: Hepatitis B;   Hepatitis B Vaccine
Intervention: Biological: Engerix™-B
40 Not yet recruiting Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Conditions: Hepatitis B;   Hepatitis A
Intervention: Procedure: Blood sampling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years